6,9-Dimethyl-3-methylene-3,3a,4,5,9a,9b-hexahydro-azuleno[4,5-b]furan-2,7-dione

ID: ALA441260

Chembl Id: CHEMBL441260

Cas Number: 36150-07-9

PubChem CID: 73440

Max Phase: Preclinical

Molecular Formula: C15H16O3

Molecular Weight: 244.29

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Dehydroleucodin | Dehydroleucodine | Dehydroleucodine|Dehydroleucodin|36150-07-9|CHEMBL441260|NSC 180034|SCHEMBL4998391|Dehydroleucodine, >=98% (HPLC)|BDBM50318392|AKOS040762600|NCGC00485131-01|(3aS,9aS,9bS)-6,9-dimethyl-3-methylidene-4,5,9a,9b-tetrahydro-3aH-azuleno[4,5-b]furan-2,7-dione|Azuleno(4,5-b)furan-2,7-dione, 3,3a,4,5,9a,9b-hexahydro-6,9-dimethyl-3-methylene-, (3aS-(3aalpha,9aalpha,9bbeta))-|HY-122295|CS-0083475|6,9-Dimethyl-3-methylene-3,3a,4,5,9a,9b-hexahydro-azuleno[4,5-b]furan-2,7-Show More

Canonical SMILES:  C=C1C(=O)O[C@@H]2[C@H]3C(C)=CC(=O)C3=C(C)CC[C@@H]12

Standard InChI:  InChI=1S/C15H16O3/c1-7-4-5-10-9(3)15(17)18-14(10)13-8(2)6-11(16)12(7)13/h6,10,13-14H,3-5H2,1-2H3/t10-,13-,14-/m0/s1

Standard InChI Key:  SKNVIAFTENCNGB-BPNCWPANSA-N

Alternative Forms

  1. Parent:

Associated Targets(Human)

NFKB2 Tchem Nuclear factor NF-kappa-B complex (2307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RELA Tchem Nuclear factor NF-kappa-B p65 subunit (627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP19A1 Tclin Cytochrome P450 19A1 (6099 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLM-13 (2241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KG-1 (867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Kasumi 1 (420 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PBMC (10003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUR (84 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa S3 (477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leukemia cell (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 244.29Molecular Weight (Monoisotopic): 244.1099AlogP: 2.34#Rotatable Bonds:
Polar Surface Area: 43.37Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.61CX LogD: 2.61
Aromatic Rings: Heavy Atoms: 18QED Weighted: 0.48Np Likeness Score: 3.09

References

1. Giordano OS, Pestchanker MJ, Guerreiro E, Saad JR, Enriz RD, Rodríguez AM, Jáuregui EA, Guzmán J, María AO, Wendel GH..  (1992)  Structure-activity relationship in the gastric cytoprotective effect of several sesquiterpene lactones.,  35  (13): [PMID:1619619] [10.1021/jm00091a013]
2. Siedle B, García-Piñeres AJ, Murillo R, Schulte-Mönting J, Castro V, Rüngeler P, Klaas CA, Da Costa FB, Kisiel W, Merfort I..  (2004)  Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB.,  47  (24): [PMID:15537359] [10.1021/jm049937r]
3. Wagner S, Hofmann A, Siedle B, Terfloth L, Merfort I, Gasteiger J..  (2006)  Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks.,  49  (7): [PMID:16570920] [10.1021/jm051125n]
4. Giordano OS, Guerreiro E, Pestchanker MJ, Guzman J, Pastor D, Guardia T..  (1990)  The gastric cytoprotective effect of several sesquiterpene lactones.,  53  (4): [PMID:2095374] [10.1021/np50070a004]
5. Guardia T, Guzman JA, Pestchanker MJ, Guerreiro E, Giordano OS..  (1994)  Mucus synthesis and sulfhydryl groups in cytoprotection mediated by dehydroleucodine, a sesquiterpene lactone.,  57  (4): [PMID:8021651] [10.1021/np50106a010]
6. Muftuoglu Y, Mustata G..  (2010)  Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).,  20  (10): [PMID:20413308] [10.1016/j.bmcl.2010.03.113]
7. Ordóñez PE, Sharma KK, Bystrom LM, Alas MA, Enriquez RG, Malagón O, Jones DE, Guzman ML, Compadre CM..  (2016)  Dehydroleucodine, a Sesquiterpene Lactone from Gynoxys verrucosa, Demonstrates Cytotoxic Activity against Human Leukemia Cells.,  79  (4): [PMID:27057812] [10.1021/acs.jnatprod.5b00383]
8. Dürr L, Reinhardt JK, Dobrzyński M, Hell T, Smieško M, Pertz O, Hamburger M, Garo E..  (2022)  A Dimerosesquiterpene and Sesquiterpene Lactones from Artemisia argyi Inhibiting Oncogenic PI3K/AKT Signaling in Melanoma Cells.,  85  (11.0): [PMID:36351173] [10.1021/acs.jnatprod.2c00471]

Source